Gabelli Funds 48th Annual Automotive Aftermarket Symposium
Logotype for NN Inc

NN (NNBR) Gabelli Funds 48th Annual Automotive Aftermarket Symposium summary

Event summary combining transcript, slides, and related documents.

Logotype for NN Inc

Gabelli Funds 48th Annual Automotive Aftermarket Symposium summary

3 Feb, 2026

Industry trends and market context

  • Used vehicle values have normalized from 2022 highs, reducing volatility in dealer and retailer earnings.

  • Incentives and inventory levels are rising, with incentives at 7.3% of average transaction price, still below pre-pandemic levels.

  • The used vehicle market, at 40 million units annually, significantly impacts automakers, rental companies, and financial services.

  • Global light vehicle production is flat, but electric and hybrid vehicle growth rates are strong, especially in China.

  • U.S. government initiatives and tariffs are influencing EV market dynamics, with OEMs adjusting strategies toward hybrids and EVs.

Company overview and transformation

  • The company is a Tier 2 automotive part maker with $500 million in revenue, 10% EBITDA, and over 3,000 employees.

  • A joint venture in China with Weifu adds $120 million in sales; the JV is profitable and unconsolidated.

  • New management initiated a transformation plan focused on growth, operational discipline, and deleveraging, with 50% of the plan completed.

  • Deleveraging efforts have reduced leverage from 3.9x to 3.0x, with about 40-50% of the turnaround plan completed.

  • Operating 25 facilities in 6 countries, with a global workforce of ~3,100 plus 700 in a China JV.

Strategic focus and growth initiatives

  • Over $113 million in new business wins from Q1'23 to Q3'24, targeting $65 million annually for the next five years.

  • The company is vertically integrated, specializing in micron-level precision parts for automotive, electrical grid, and orthopedics.

  • China is a key market, with the largest customer BYD expanding globally; new factories are being built to support growth.

  • Medical market re-entry is underway, targeting $100 million in sales by 2028 through organic growth and acquisitions.

  • Orthopedic implant parts represent a new, high-growth market, with global joint replacement sales expected to grow 6% in 2024.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more